Eli Lilly’s New Drug Retatrutide Shows Significant Weight Loss Results in Clinical Trials
The trial, which concluded in early October 2023, included over 400 participants who were administered varying doses of Retatrutide. The results were presented at the Obesity Society’s annual meeting, highlighting the drug’s efficacy not only in weight loss but also in improving metabolic health markers such as blood sugar levels and cholesterol. These findings are … Read more